Supplementary Figure 2 from Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: an Open-Label Phase I Trial
openalex(2023)
摘要
Lymphocyte recovery is a probable indictor of response.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要